Вторые опухоли у лиц, подвергавшихся противоопухолевой терапии в детском возрасте. Статистика, этиология, пути профилактики

Бесплатный доступ

Проведен анализ литературы, посвященной отдаленным последствиям противоопухолевого лечения у детей и подростков. Констатировано, что в отдаленные сроки после излечения первичной опухоли основными проблемами становятся вторые опухоли и сердечно-сосудистая патология. Основным фактором индукции вторых опухолей является лучевая терапия. Вероятность развития последствий терапии находится в прямой корреляции с величиной дозы облучения и временем, прошедшим после лечения. Результаты анализа свидетельствуют о целесообразности пересмотра показаний к проведению консолидирующей лучевой терапии, с отказом от нее в случаях благоприятного прогноза и полной регрессии опухоли в результате операции или химиотерапии. При наличии необходимости в лучевой терапии лечение должно проводиться в максимально щадящем режиме с применением стереотаксических методик, современной радиотерапевтической аппаратуры и в минимально возможных дозах. Больные, получавшие противоопухолевую терапию в юном возрасте, должны находиться пожизненно под диспансерным наблюдением онкологов с особым вниманием к зонам, подвергавшимся облучению.

Еще

Опухоли у детей, отдаленные последствия, лучевая терапия, радиационный канцерогенез

Короткий адрес: https://sciup.org/14955408

IDR: 14955408

Список литературы Вторые опухоли у лиц, подвергавшихся противоопухолевой терапии в детском возрасте. Статистика, этиология, пути профилактики

  • Armstrong G.T., Liu Q., Yasui Y. et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.//J Natl Cancer Inst. 2009. V. 101. N13. P.946-958.
  • Armstrong G.T., Stovall M., Robison L.L. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study.//Radiat Res. 2010. V. 174. N 6. P. 840-850.
  • Barbaro P.M., Johnston K., Dalla-Pozza L. et al. Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy.//Ann Oncol. 2011. V. 22. N12. P. 2569-2574.
  • Castellino S.M., Geiger A.M., Mertens AC et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.//Blood. 2011. V. 117. N 6. P. 1806-1816.
  • Dorffel W., Ruhl H., Luders H. et al. Treatment of children and adolescents with Hodgkin Lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.//J.Clin Oncol. 2013. V. 31. N 12. P. 1562-1568.
  • Friedman D.L., Whitton J., Leisenring W. et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.//J Natl Cancer Inst. 2010. V. 102. N14. P. 1083-1095.
  • Henderson T.O., Oeffinger K.C., Whitton J. et al. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.//Ann Intern Med. 2012. V. 156. N 11. P. 757-766.
  • Galloway T.J., Indelicato D.J., Amdur R.J. et al. Second tumors in pediatric patients treated with radiotherapy to the central nervous system.//Am J Clin Oncol. 2012. V. 35. N 3. P. 279-283.
  • Garwicz S., Anderson H., Olsen J.H. et al. Late and very late mortality in 5-year survivors of childhood cancer: Changing pattern over four decades-Experience from the Nordic countries.//Int J Cancer. 2012. V. 131. N7. P. 1659-1666.
  • Armstrong G.T., Robison L.L., Liu W. et al. Occurrence of Multiple Subsequent Neoplasms in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.//Eur J Cancer. 2003. V. 39, N16. P. 2379-2386.
  • Guérin S., Dupuy A., Anderson H. et al. Radiation dose as a risk factor for malignant melanoma following childhood cancer.//Eur J Cancer. 2003. V. 39. N 16. P. 2379-2386.
  • Li F.P., Cassady J.R., Jaffe N. Risk of second tumors in survivors of childhood Cancer.//Cancer. 1975. V. 35. N4. P. 1230-1235.
  • Lorenzo Y., Provencio M., Lombardia L. et al. Differential genetic and functional markers of second neoplasias in Hodgkin's disease patients.//Clin Cancer Res. 2009. V. 15. N15. P. 4823-4828.
  • Metzger M.L., Weinstein H.J., Hudson M.M. et al. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.//JAMA. 2012. V. 307, N24. P. 2609-2616.
  • Milano M.T., Li H., Gail M.H. et al. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.//J Clin Oncol. 2010. V. 28. N34. P. 5088-5096.
  • Norberg L., Johansson R., Rasmuson T. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden.//Acta Oncol. 2010. V. 49, N8. P. 1276-1282.
  • O'Brien M.M., Donaldson S.S., Balise R.R. et al. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.//J Clin Oncol. 2010.V. 28. N 7. P. 1232-1239.
  • Olsen J.H., Garwicz S., Hertz H. et al. Second cancer. Risk of a second malignant neoplasm in persons with cancer in childhood and adolescence.//Ugeskr Laeger. 1994. V. 156. N 32. P. 4565-4571.
  • Olsen J.H., Möller T., Anderson H. et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.//J Nat. Cancer Inst. 2009. V. 101, N11. P. 806-813.
  • Omer B., Kadan-Lottick N.S., Roberts K.B. et al. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults.//Br J Haematol. 2012. V. 158. N 5. P. 615-625.
  • Patel A.J., Rao V.Y., Fox B.D. et al. Radiation-induced osteosarcomas of the calvarium and skull base.//Cancer. 2011. V. 117. N10. P. 2120-2126.
  • Reulen R.C., Frobisher C., Winter D.L. et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.//JAMA. 2011. V. 305. N 22. P. 2311-2319.
  • Reulen R.C., Winter D.L., Frobisher C. et al. Long-term cause-specific mortality among survivors of childhood cancer.//JAMA. 2010. V. 304. N 2. P. 172-179.
  • Rihani R., Bazzeh F., Faqih N. et al. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.//Cancer. 2010. V. 116. N 18. P. 4385-4394.
  • Robison L.L. Late effects of acute lymphoblastic leukemia therapy in patients diagnosed at 020 years of age.//Hematology Am Soc Hematol Educ Program. 2011. N 2011. P. 238-242.
  • Sankila R., Garwicz S., Olsen J.H. et al. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric ematology and Oncology.//J Clin Oncol. 1996. V. 14, N 5. P. 1442-1446.
  • Sun W.F., Cheng F.W., Lee V. et al. Second malignant neoplasms in childhood cancer survivors in a tertiary paediatric oncology centre in Hong Kong, China.//Chin Med J. 2011. V. 124. N22. P. 3686-3692.
  • Svahn-Tapper G., Garwicz S., Anderson H. et al. Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.//Acta Oncol. 2006. V. 45. N 4. P. 38-48.
  • Taylor A.J., Frobisher C., Ellison D.W. et al. Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer. Survivor Study.//J Clin Oncol. 2009. V. 27. N 34. P. 5781-5787.
  • Taylor A.J., Little M.P., Winter D.L. et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study.//J Clin Oncol. 2010. V. 28. N 36. P. 5287-5293.
  • Toda K., Shibuya H., Hayashi K., Ayukawa F. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.//Radiat Oncol. 2009. V. 10. N 4. P. 21 -24.
  • Travis L.B., Ng A.K., Allan J.M. et al. Second malignant neoplasms and cardiovascular disease following radiotherapy.//J Natl Cancer Inst. 2012. V. 104. N 5. P. 357-370.
  • Tukenova M., Diallo I., Anderson H. et al. Second malignant neoplasms in digestive organs after childhood cancer: a cohort-nested case-control study.//Int J Radiat Oncol Biol Phys. 2012. V. 82. N 3. P. 383-390.
  • Tukenova M., Guibout C., Hawkins M. et al. Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood.//Int J Radiat Oncol Biol Phys. 2011. V. 80. N 2. P. 339-346.
  • Valdivieso M., Kujawa A.M., Jones T. et al. Cancer survivors in the United States: a review of the literature and a call to action.//Int J Med Sci. 2012. V. 9, N 2. P. 163-173.
  • Welte B., Suhr P., Bottke D. et al. Second malignancies in high-dose areas of previous tumor radiotherapy.//Strahlenther Onkol. 2010. V. 186. N 3. P. 174-179.
  • Wilson C.L., Cohn R.J., Johnston K.A. et al. Late mortality and second cancers in an Australian cohort of childhood cancer survivors.//Med J Aust. 2010. V. 193, N 5. P. 258-261.
Еще
Статья обзорная